Patents by Inventor Deborah Nusskern

Deborah Nusskern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER
    Publication number: 20140057260
    Abstract: Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.
    Type: Application
    Filed: August 22, 2013
    Publication date: February 27, 2014
    Applicant: Euclid Diagnostics LLC
    Inventors: Wadiha Freije, Deborah Nusskern
  • MATERIALS AND METHODS FOR CANCER DIAGNOSIS BY EVALUATION OF THE METHYLATION STATUS OF CPG ISLANDS ON CHROMOSOMES 6 AND 8
    Publication number: 20130288967
    Abstract: Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.
    Type: Application
    Filed: April 25, 2013
    Publication date: October 31, 2013
    Applicant: EUCLID DIAGNOSTICS LLC
    Inventors: Wadiha FREIJE, Igor BRIKUN, Deborah NUSSKERN
  • Materials and method for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
    Patent number: 8546078
    Abstract: Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.
    Type: Grant
    Filed: January 3, 2011
    Date of Patent: October 1, 2013
    Assignee: Euclid Diagnostics LLC
    Inventors: Wadiha Freije, Deborah Nusskern
  • MATERIALS AND METHOD FOR ASSAYING FOR METHYLATION OF CpG ISLANDS ASSOCIATED WITH GENES IN THE EVALUATION OF CANCER
    Publication number: 20110097728
    Abstract: Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.
    Type: Application
    Filed: January 3, 2011
    Publication date: April 28, 2011
    Applicant: EUCLID DIAGNOSTICS LLC
    Inventors: Wadiha Freije, Deborah Nusskern
  • Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
    Publication number: 20080213791
    Abstract: Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of prognosticating cancer and methods of assessing the efficacy of cancer treatment. The methods include assaying a biological sample for methylation of a CpG island associated with specified genes. Provided reagents and kits include primers suitable for amplifying at least a portion of a target CpG islands associated with specified genes.
    Type: Application
    Filed: May 6, 2008
    Publication date: September 4, 2008
    Applicant: EUCLID DIAGNOSTICS LLC
    Inventors: Wadiha Freije, Deborah Nusskern